en.wikipedia.org/wiki/Torosyan_v._Boehringer_Ingelheim_Pharmaceuticals,_Inc.

Torosyan v Boehringer Ingelheim Pharmaceuticals, Inc, 662 A2d 89 (1995) is a US labor law case, concerning the contract of employment in state law for labor ...

www.law360.com/cases/55c120da7e21ae3645000003

... INC. et al v. HEC PHARM GROUP et al, case number 3:15-cv-05982, from New Jersey Court. ... BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. ...... GREGORY D. MILLER, RIVKIN RADLER LLP TERMINATED: 03/16/2016.

www.cadc.uscourts.gov/internet/opinions.nsf/A81BAEEA3D756416852582B100518ADF/$file/16-5356.pdf

Jun 19, 2018 ... With him on the briefs were Michael Sennett and Nicole C. ... Boehringer Ingelheim Pharmaceuticals, Inc. Warren D. .... no privilege at all.

www.ftc.gov/system/files/documents/cases/boehringer_dccir_ftc_reply_and_response_brief_2017-0717_0.pdf

Jul 17, 2017 ... In re Miller, 438 F.3d 1141 (D.C. Cir. 2006) . .... in district court case below (FTC v. Boehringer Ingelheim Pharmaceuticals, Inc., Case ..... would not suddenly abdicate all of her legal skills and training and consider. USCA Case ...

www.ftc.gov/system/files/documents/cases/boehringer_dccir_ftc_opening_brief_2017-0327.pdf

Mar 27, 2017 ... Boehringer Ingelheim Pharmaceuticals, Inc. (“Boehringer”) was the ... FTC v. Boehringer Ingelheim Pharmceuticals, Inc. 778 F.3d 142 (D.C. Cir. ..... overly broad privilege claims covering virtually all documents related to the ...

casetext.com/case/torosyan-v-boehringer-ingelheim-pharmaceuticals-inc

v. Boehringer Ingelheim Pharmaceuticals, Inc. Not overruled or negatively treated on ... On September 11, 1996, a second interoffice memo was sent to "All CIM ...

www.lungcancerjournal.info/article/S0169-5002(17)30487-7/pdf

Vincent A. Millerf, William Paoa,1, Matthias Freiwaldg, Jean Fanh, Bushi ... h Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, ... tinib, and afatinib, all of which are approved as first-line treatment in .... [21] aIncluding the six patients treated in the dose-finding phase previously reported by Janjigian Y, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4155006

Jul 29, 2014 ... All patients (except those enrolled only in the dose-finding phase) had a ... authors and the sponsor, Boehringer Ingelheim Pharmaceuticals Inc. Study ..... Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, et al.